Cargando…

Breastfeeding and treatment of multiple sclerosis

Detalles Bibliográficos
Autor principal:	Celius, Elisabeth G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Case Report and Clinical Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983324/ https://www.ncbi.nlm.nih.gov/pubmed/32507035 http://dx.doi.org/10.1177/1352458520931786

Ejemplares similares

Normal antibody response after COVID-19 during treatment with cladribine
por: Celius, Elisabeth G.
Publicado: (2020)

Management of Severe Graves’ Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis
por: Hammerstad, Sara Salehi, et al.
Publicado: (2021)

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
por: Celius, Elisabeth G., et al.
Publicado: (2018)

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis
por: Toorop, Alyssa A, et al.
Publicado: (2021)

Vaccine regulation should require and enforce the inclusion of pregnant and breastfeeding women in prelicensure clinical trials
por: Manca, Terra A., et al.
Publicado: (2022)

European and American Guidelines for Multiple Sclerosis Treatment
por: Ghezzi, Angelo
Publicado: (2018)

COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?
por: Brownlee, Wallace J
Publicado: (2020)

In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?
por: Kilsdonk, Iris D, et al.
Publicado: (2017)

Management of Multiple Sclerosis in the Breastfeeding Mother
por: Almas, Saneea, et al.
Publicado: (2016)

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
por: Wurm, Hannah, et al.
Publicado: (2020)

Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series
por: Al-Louzi, Omar, et al.
Publicado: (2017)

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary
por: Dobson, Ruth, et al.
Publicado: (2022)

Is the central vein sign a useful diagnostic marker for paediatric-onset multiple sclerosis?
por: Abdel-Mannan, Omar, et al.
Publicado: (2022)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

High prevalence of fatigue in contemporary patients with multiple sclerosis
por: Broch, Line, et al.
Publicado: (2021)

The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients
por: Kloc, Malgorzata, et al.
Publicado: (2020)

Questioning current definitions for breastfeeding research
por: Noel-Weiss, Joy, et al.
Publicado: (2012)

Markets, breastfeeding and trade in mothers’ milk
por: Smith, Julie P
Publicado: (2015)

Breastfeeding in public: “You can do it?”
por: Amir, Lisa H
Publicado: (2014)

Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

An insight about genomic susceptibility & multiple sclerosis
por: Verma, Rajesh, et al.
Publicado: (2017)

Chewing the fat on an emerging target in multiple sclerosis
por: Lim, Chai K.
Publicado: (2021)

Seeking neuroprotection in multiple sclerosis: an ongoing challenge
por: Antel, Jack P., et al.
Publicado: (2023)

Multiple Sclerosis Treatment and Melanoma Development
por: Carbone, Maria Luigia, et al.
Publicado: (2020)

Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
por: Hartung, Hans-Peter, et al.
Publicado: (2021)

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
por: Steinberg, Judith, et al.
Publicado: (2019)

Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
por: Craner, Matthew, et al.
Publicado: (2022)

Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting
por: Svenningsson, Anders, et al.
Publicado: (2013)

B cells and multiple sclerosis spinal cord pathology
por: Schmierer, Klaus, et al.
Publicado: (2020)

Multiple sclerosis: major histocompatibility complexity and antigen presentation
por: Ramagopalan, Sreeram V, et al.
Publicado: (2009)

Serum markers of multiple sclerosis - a new approach
por: Torkildsen, Øivind
Publicado: (2021)

Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
por: Avolio, Carlo, et al.
Publicado: (2021)

Monkeypox in Multiple Sclerosis patients: Should we be alert?
por: Boldrini, Vinícius Oliveira, et al.
Publicado: (2022)

Treatment of Multiple Sclerosis With Chinese Scalp Acupuncture
por: Hao, Jason Jishun, et al.
Publicado: (2013)

Orthodontic treatment for a patient with multiple sclerosis
por: Bakathir, Manal A
Publicado: (2017)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
por: Yeandle, David, et al.
Publicado: (2018)

Fungal microbiome and multiple sclerosis: The not-so-new kid on the block
por: Mangalam, Ashutosh K.
Publicado: (2021)

Similarities and differences between multiple sclerosis and type 1 diabetes
por: Pozzilli, Valeria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ee23nn7bg099llkre45tnsbej6